Page last updated: 2024-11-05

tinopal

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth

Description

Tinopal: fluorescent whitening agents or optical brightners; used in detergents; RN given refers to parent cpd without isomeric designation [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

Cross-References

ID SourceID
PubMed CID5750263
SCHEMBL ID461641
MeSH IDM0057923

Synonyms (14)

Synonym
(e)-4,4'-bis[(4-anilino-6-morpholino-s-triazin-2-yl)amino]-2,2'-stilbenedisulfonic acid
tinopal
4,4'-bis((4-anilino-6-morpholino-1,3,5-triazin-2-yl)amino)stilbene-2,2'-disulphonic acid
einecs 246-097-5
benzenesulfonic acid, 2,2'-(1,2-ethenediyl)bis(5-((4-(4-morpholinyl)-6-(phenylamino)-1,3,5-triazin-2-yl)amino)-
(e)-4,4'-bis((4-anilino-6-morpholino-s-triazin-2-yl)amino)-2,2'-stilbenedisulfonic acid
32466-46-9
2,2'-stilbenedisulfonic acid, 4,4'-bis((4-anilino-6-morpholino-s-triazin-2-yl)amino)-, (e)-
benzenesulfonic acid, 2,2'-(1,2-ethenediyl)bis[5-[[4-(4-morpholinyl)-6-(phenylamino)-1,3,5-triazin-2-yl]amino]-
SCHEMBL461641
(e)-6,6'-(ethene-1,2-diyl)bis(3-((4-morpholino-6-(phenylamino)-1,3,5-triazin-2-yl)amino)benzenesulfonic acid)
DTXSID40892587
2,2'-[(e)-1,2-ethenediyl]bis(5-{[4-anilino-6-(4-morpholinyl)-1,3,5-triazin-2-yl]amino}benzenesulfonic acid)
(e)-6,6'-(ethene-1,2-diyl)bis(3-((4-morpholino-6-(phenylamino)-1,3,5-triazin-2-yl)amino)benzenesulfonicacid)
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (11)

TimeframeStudies, This Drug (%)All Drugs %
pre-19901 (9.09)18.7374
1990's2 (18.18)18.2507
2000's7 (63.64)29.6817
2010's1 (9.09)24.3611
2020's0 (0.00)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials1 (9.09%)5.53%
Reviews0 (0.00%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other10 (90.91%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]